Análisis Argos
ASTH
ASTHCara1 señal de riesgo
Astrana Health, Inc. · Healthcare
US$ 49.17
precio al 2026-07-04
Valor justo Argos*
US$ 30
vs. su valor justo
−39%
Score Argos
22/100
LA RESPUESTA
El mercado le pide crezca 49% al año — más de lo que ha demostrado (3.8%). Estás pagando un futuro que todavía no probó: el margen de error es mínimo.
Recompensas
Sin recompensas destacadas.
Riesgos
!El precio pide más crecimiento del que la empresa ha demostrado.
!Balance frágil: la deuda pesa sobre el negocio.
!Piotroski F-Score débil (3/9)
VALOR1/6FUTURO6/6PASADO1/6SALUD1/6DIVIDENDO2/6
El Iris de calidad
VALOR1/6FUTURO6/6PASADO1/6SALUD1/6DIVIDENDO2/6
ValorCotiza por encima de su valor justo
FuturoIngresos creciendo con fuerza
PasadoHistorial débil
SaludBalance frágil
DividendoRetorno al accionista moderado
Score Argos22de 100Cara
Ingresos57%
US$ 3.2 B
Margen operativo43%
2.5%
Flujo de caja libre150%
US$ 0.1 B
Deuda neta
US$ 0.7 B
Lo esencial, sin ruido
Cap. de mercadoUS$ 2.4B
P/E108.4x
EV/EBITDA24.8x
FCF yield4.3%
ROIC3.3%
Margen operativo2.5%
Crecim. ingresos+56.4%/año
Piotroski F3/9
Competidores

Los rivales, con el mismo ojo

El Iris de calidad de cada competidor, lado a lado. Tocá uno para ver su análisis.

Novedades

Noticias recientes

prnewswire.com · 4 jun
Astrana Health Named to the 2026 Fortune 1000 List Following Strong Revenue Growth
ALHAMBRA, Calif., June 4, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a physician-centric, technology-enabled healthcare company empowering providers to deliver accessible, high-quality, and high-value care to all, today announced it has been named to the Fortune 1000® for 2026, marking its debut on the annual ranking of the largest U.S. companies by revenue.
marketbeat.com · 12 may
Astrana Health Says Prospect Deal Is Ahead of Schedule as Q1 Trends Beat Expectations
Astrana Health NASDAQ: ASTH CEO and President Brandon Sim said the value-based care company is seeing early benefits from its acquisition of Prospect, while reporting stronger-than-expected first-quarter trends across medical costs, free cash flow and revenue.
seekingalpha.com · 12 may
Astrana Health, Inc. (ASTH) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Astrana Health, Inc. (ASTH) Presents at Bank of America Global Healthcare Conference 2026 Transcript
prnewswire.com · 12 may
Astrana Health, Inc. Announces Appointment of Interim National Medical Director
ALHAMBRA, Calif., May 12, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a physician-centric, technology-enabled healthcare company empowering providers to deliver accessible, high-quality, and high-value care to all, today announced the appointment of George Christides, M.D.
prnewswire.com · 11 may
Physician Association of California and Astrana Health Launch Collaboration to Strengthen Independent Primary Care
Expands access to Astrana's Medicare ACO platform, powered by a unified AI-powered platform designed for independent physicians ALHAMBRA, Calif., May 11, 2026 /PRNewswire/ -- The Physician Association of California ("PAC") and Astrana Health, Inc. ("Astrana") (NASDAQ: ASTH), a physician-centric, technology-enabled healthcare company empowering providers to deliver accessible, high-quality, and high-value care to all, today announced a collaboration to help independent primary care physicians remain independent – and succeed – in an increasingly complex healthcare system while improving patient care.
seekingalpha.com · 8 may
Astrana Health, Inc. (ASTH) Q1 2026 Earnings Call Transcript
Astrana Health, Inc. (ASTH) Q1 2026 Earnings Call Transcript
zacks.com · 7 may
Astrana Health, Inc. (ASTH) Surpasses Q1 Earnings and Revenue Estimates
Astrana Health, Inc. (ASTH) came out with quarterly earnings of $0.74 per share, beating the Zacks Consensus Estimate of $0.29 per share. This compares to earnings of $0.14 per share a year ago.
prnewswire.com · 7 may
Astrana Health, Inc. Reports First Quarter 2026 Results
Company to Host Conference Call on Thursday, May 7, 2026, at 2:30 p.m. PT/5:30 p.m.

* Valor justo Argos: estimación educativa del valor intrínseco según el propio flujo de caja de la empresa y su capacidad de crecimiento — no un precio objetivo ni una recomendación. Esto es información y educación, no asesoría de inversión. Rendimiento pasado no garantiza resultados futuros.